How much did Rybrevant (amivantamab) sell in 2023?
I can’t answer this as stated because no sales figures or context were provided (e.g., whether you mean global revenue, U.S. sales only, net sales vs. gross sales, or a specific company filing). “Rybrevant sales 2023” is often reported in different ways depending on the data source.
If you share the country/metric you mean (global net sales, U.S. revenue, etc.) or a link to the report you’re looking at, I can summarize the exact 2023 numbers and cite the source.
What filings or sources usually report Rybrevant 2023 sales?
For oncology drugs like Rybrevant, sales in 2023 are typically pulled from:
- Company financial statements (e.g., year-end and quarterly results)
- Annual reports (10-K/20-F style filings) and segment/product disclosures
- Pharmacy/market research datasets, if you’re using a third-party estimate
Are you looking for specific revenue totals (e.g., J&J “Rybrevant” 2023 revenue)?
Rybrevant is marketed by Janssen (Johnson & Johnson). If you mean “Janssen/Rybrevant revenue in 2023,” tell me the geography (U.S. or worldwide) and the metric (net sales vs. sales estimate), and I’ll format the answer to match what you need.
Do you want U.S. sales, global sales, or third-party estimates?
“Sales” can mean:
- U.S. net product sales
- Worldwide net product sales
- Estimates from analysts/market research
Reply with one of these (U.S., global, or estimate), and I’ll respond with the right 2023 figure(s) and a source link.